MedPath

Diamicron

Brand Name: Diamicron

Generic Name: Gliclazide

Active
Registration Number

DR-X626

Dosage Form

Tablet

Issuance Date

February 1, 2023

Expiry Date

March 20, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength80mg
PackagingBlister pack

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Oral Hypoglycemic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

GliclazideActive
Monograph: Gliclazide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform